![glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://static.elsevier.es/multimedia/00017310/0000011500000001/v1_202401030514/S0001731023008505/v1_202401030514/en/main.assets/fx1.jpeg)
glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1
USD21.80
USD59.80
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
![glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://cdn.sanity.io/images/0vv8moc6/dermatologytimes/8e282d6f45124a8e8c8f0c4db3aaf85d6cbcac1b-4058x2848.jpg)
![glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://jcadonline.com/wp-content/uploads/Cotter2_Figure1.jpg)
![glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://www.medicalindependent.ie/wp-content/uploads/2025/10/psoriasis-patients.jpg)
![glp 1 for psoriasis Translated article] Glucagon-Like Peptide-1 Agonists Treating Obesity in Patients With Immune-Mediated Skin Diseases Exploring the Role of GLP-1](https://ars.els-cdn.com/content/image/1-s2.0-S1568997225001247-gr1.jpg)
